Werewolf Therapeutics Inc
NASDAQ:HOWL 4:00:00 PM EDT
Market Cap (Intraday) | 271.38M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $6.20 |
50-Day MA | $6.02 |
200-Day MA | $3.64 |
Werewolf Therapeutics Inc Stock, NASDAQ:HOWL
200 Talcott Avenue, 2nd floor, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.952.0555
Number of Employees: 47
Description
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body�s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.